Ledger.Open graph →
SEC Form D · filed October 11, 2016

LifeMine Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Gregory L. Verdine · Cambridge, MAExec · DirectorWeiqing L. Zhou · Cambridge, MAExec · DirectorHingge L. Hsu · Cambridge, MAExec · DirectorGregory L. Verdine · Cambridge, MAExec · DirectorHingge L. Hsu · Cambridge, MAExec · DirectorWeiqing L. Zhou · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗